These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9437828)

  • 1. Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function.
    Greenwood JD; Croy BA; Trout DR; Wilcock BP
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):93-112. PubMed ID: 9437828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
    Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
    Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
    Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Offspring of xenogeneically-reconstituted scid/scid mice are capable of a primary xenogeneic immune response to DNP-KLH.
    Greenwood JD; Bos NA; Croy BA
    Vet Immunol Immunopathol; 1996 Mar; 50(1-2):145-55. PubMed ID: 9157679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the engraftment and trafficking of bovine peripheral blood leukocytes in severe combined immunodeficient mice.
    Greenwood JD; Croy BA
    Vet Immunol Immunopathol; 1993 Sep; 38(1-2):21-44. PubMed ID: 8256436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
    Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
    Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
    Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.
    Murray AG; Schechner JS; Epperson DE; Sultan P; McNiff JM; Hughes CC; Lorber MI; Askenase PW; Pober JS
    Am J Pathol; 1998 Aug; 153(2):627-38. PubMed ID: 9708821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human peripheral blood lymphocyte-reconstituted, severe combined immunodeficient mice as a model for porcine islet xenograft rejection in humans.
    Shiroki R; Nazirrudin B; Hoshinaga K; Naide Y; Scharp DW; Mohanakumar T
    Artif Organs; 1996 Aug; 20(8):878-82. PubMed ID: 8853799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
    Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
    Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S; Smith FO; Ochs HD
    J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
    J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
    Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
    Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the immune system in severe combined immunodeficiency mice reconstituted with transferred fetal liver cells.
    Wakabayashi A; Eishi Y; Nakamura K
    J Med Dent Sci; 1997 Mar; 44(1):21-9. PubMed ID: 9385039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary human immune response to Neisseria meningitidis serogroup C in interleukin-12-treated severe combined immunodeficient mice engrafted with human peripheral blood lymphocytes.
    Westerink MA; Metzger DW; Hutchins WA; Adkins AR; Holder PF; Pais LB; Gheesling LL; Carlone GM
    J Infect Dis; 1997 Jan; 175(1):84-90. PubMed ID: 8985200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells.
    Gysemans C; Waer M; Laureys J; Depovere J; Pipeleers D; Bouillon R; Mathieu C
    Clin Exp Immunol; 2000 Sep; 121(3):557-65. PubMed ID: 10971525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human TNF can induce nonspecific inflammatory and human immune-mediated microvascular injury of pig skin xenografts in immunodeficient mouse hosts.
    Kirkiles-Smith NC; Tereb DA; Kim RW; McNiff JM; Schechner JS; Lorber MI; Pober JS; Tellides G
    J Immunol; 2000 Jun; 164(12):6601-9. PubMed ID: 10843720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.